Key terms

About QGEN

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest QGEN news

Mar 01 3:25am ET UBS Sticks to Their Hold Rating for Qiagen (QGEN) Feb 16 9:37am ET UPS upgraded, Nike downgraded: Wall Street’s top analyst calls Feb 16 7:52am ET Qiagen upgraded to Overweight from Equal Weight at Morgan Stanley Feb 16 3:05am ET Berenberg Bank Reaffirms Their Buy Rating on Qiagen (QGEN) Feb 15 9:25pm ET Goldman Sachs Reaffirms Their Sell Rating on Qiagen (QGEN) Feb 09 12:57am ET Buy Recommendation for Qiagen: Anticipated Growth and Strategic Underpromise Feb 08 8:35pm ET Kepler Capital Keeps Their Hold Rating on Qiagen (QGEN) Feb 08 6:38am ET Qiagen price target lowered to $60 from $61.86 at Citi Feb 08 5:18am ET Maintaining Buy on Qiagen: Strong Q4 Performance and Positive Long-Term Outlook Feb 07 9:40pm ET Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN) and Ascendis Pharma (ASND) Feb 07 8:41am ET UBS Remains a Hold on Qiagen (QGEN) Feb 07 8:41am ET Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Qiagen (QGEN) and Inspire Medical Systems (INSP) Feb 07 8:40am ET Stifel Nicolaus Sticks to Their Hold Rating for Qiagen (QGEN) Feb 07 8:21am ET Analysts’ Top Healthcare Picks: Amgen (AMGN), Qiagen (QGEN) Feb 07 7:10am ET Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN), Inspire Medical Systems (INSP) and Gilead Sciences (GILD) Feb 06 9:30pm ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN), Qiagen (QGEN) and Waters (WAT) Feb 06 4:18pm ET Qiagen reports Q4 EPS 55c consensus 55c Feb 06 9:48am ET Qiagen rumor highlighted again in Betaville blog Jan 31 1:18pm ET Qiagen price target lowered to EUR 47 from EUR 48.45 at Morgan Stanley Jan 26 8:50pm ET Analysts Conflicted on These Healthcare Names: HCA Healthcare (HCA), Thermo Fisher (TMO) and Qiagen (QGEN) Jan 26 8:10am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (OtherSNYNF) and Qiagen (QGEN) Jan 25 10:02am ET Qiagen partners with Penn State to advance microbiome sciences Jan 18 4:16pm ET Qiagen announces details for completion of share repurchase up to $300M Jan 18 10:05am ET Berenberg Bank Remains a Buy on Qiagen (QGEN) Jan 10 8:40pm ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Qiagen (QGEN) and Medios AG (OtherMEDOF) Jan 08 6:50am ET Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE), Qiagen (QGEN) and Alnylam Pharma (ALNY) Jan 08 5:48am ET Qiagen receives FDA clearance for NeuMoDx CT/NG Assay 2.0 Jan 08 4:35am ET Morgan Stanley Remains a Buy on Qiagen (QGEN) Jan 07 2:00pm ET Qiagen announces plans to return approximately $300M to shareholders Jan 07 7:21am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Siemens Healthineers AG (OtherSEMHF), Qiagen (QGEN) and Medios AG (OtherMEDOF) Jan 03 7:26am ET Jefferies Sticks to Its Hold Rating for Qiagen (QGEN)

No recent news articles are available for QGEN

No recent press releases are available for QGEN

QGEN Financials

1-year income & revenue

Key terms

QGEN Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

QGEN Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms